Clinical Trial Update: Safety and Tolerability of Intravitreal VEGF Trap Formulations in Subjects With Neovacular AMD [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and tolerability of intravitreal VEGF trap formulations in patients with neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Aflibercept (Aflibercept)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Neovascular Age Related Macular Degeneration | Phase 1 | Status: COMPLETED